Amino acids

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Amino acids
Accession Number
DB09393
Description

Mixture of amino acids ; used for parenteral nutrition in infants.

Type
Small Molecule
Groups
Investigational
Synonyms
  • Amino acids NOS

Pharmacology

Indication
Not Available
Associated Conditions
Associated Therapies
Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Categories

ATC Codes
B05BA01 — Amino acids
Drug Categories
Classification
Not classified

Chemical Identifiers

UNII
0O72R8RF8A
CAS number
65072-01-7

References

General References
Not Available
Wikipedia
Amino_acids

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4CompletedTreatmentNephropathy, Diabetic1
4Unknown StatusTreatmentMuscular Atrophy1
3RecruitingTreatmentSurgery, Cardiac1
2Active Not RecruitingTreatmentConcussion, Brain1
2CompletedTreatmentMalnutrition1
2RecruitingPreventionMuscle Wasting / Quality of Life1
2RecruitingTreatmentAcute Respiratory Failure1
2RecruitingTreatmentMedulloblastomas / Meningiomas / Neuroblastomas / Neuroendocrine Tumors1
2WithdrawnTreatmentMedulloblastomas / Meningiomas / Neuroblastomas / Neuroendrocrine Tumors1
1Unknown StatusSupportive CareInsulin Resistance1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection, solution4 G/100ML
Injection, solutionIntravenous4 G/100ML
SolutionIntravenous4 G/100ML
Injection, solution5.3 G/100ML
Injection, solutionIntravenous5.3 G/100ML
Injection, solution8 G/100ML
Injection, solutionIntravenous8 G/100ML
Injection, solutionIntravenous15 g/100mL
InjectionIntravenous10 %
SolutionIntravenous10 %
Injection, solutionIntravenous10 g/100mL
Injection, solutionIntravenous5 g/100mL
Tablet68 g/100g
Injection, solution5.3 %
Tablet, coatedOral600 mg
Solution500 ml
SolutionIntravenous500 ml
Injection, solutionIntravenous7 g/100mL
SolutionIntravenous250 ml
SolutionIntraperitoneal510 mg/l
Injection, solutionIntravenous2.7 g/100mL
Injection, solution4 %
Injection, solution40 MG/ML
Injection, solutionIntravenous40 mg/ml
Injection, solutionIntravenous250 ml
Injection, solutionIntravenous500 ml
Injection, solutionIntravenous6.53 g/100mL
Solution100 ml
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
Not Available
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Drug created on November 30, 2015 12:10 / Updated on June 12, 2020 10:52

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates